ARS Pharmaceuticals Inc. Common Stock. Replay the stock market charts of SPRY day by day, back to 2003. Open long and short positions without spending any money. ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe allergic reactions to food, medications, and insect bites. Its product includes Neffy, a low-dose intranasal epinephrine nasal spray. The company was incorporated in 2015 and is based in San Diego, California.
